You have a question? Need information? Contact ESHRE Central Office.
Lithuanian President Dalia Grybauskaite’s veto of restrictive regulations in reproductive medicine was supported by the Lithuanian Parliament on Saturday 10th September 2016. The vote also introduced a new ART legislation, which opens the access to fertility treatment for Lithuanian families.
ESHRE had formally expressed its support to Lithuanian medical specialists and to the President in her veto. As proposed, the changes to Lithuania's regulation of IVF and other fertility treatments would have applied restrictions likely to limit access to treatments and even jeopardised patient safety. The new legislation passed along with the veto now allows state-funded IVF, the freezing of embryos, PGD for the identification and prevention of genetic defects in the embryos of at-risk couples and gamete donation.
Read more >
Download the pdf >
Fertility experts call for full information on composition of culture media to be made available
Fertility experts are calling on the companies who make the solutions in which embryos are cultured during in vitro fertilisation (IVF) to give a clear list of ingredients following publication of a trial that shows that the composition of these laboratory cultures affects the outcomes of the resulting embryos and babies. Read more>
The new edition, published as an online document, provides the additional advantages of flexibility for revision and ease of consultation.
ESHRE's much anticipated e-learning service e-Campus, with more than 250 hours of courses on various subjects, is now ready and available to ESHRE members.
We have developed a printable pocket version of the ESHRE guideline: Routine psychosocial care in infertility and medically assisted reproduction – A guide for fertility staff.
Print it and keep it on your desk!
The guideline was also published in Human Reproduction. You can read the full guideline and find all available details on this page.
ESHRE's review journal Human Reproduction Update, for many years the leading title in the citation categories of Reproductive Biology and O&G, has seen its impact factor rise from 10.165 to 11.194 in the latest journal analysis released in June. This is the highest recorded impact factor ever in these two categories.
Both of ESHRE’s other two titles also increased their impact factor from last year. Molecular Human Reproduction rose from 3.747 to 3.943, and ESHRE's flagship title Human Reproduction confirmed its high-ranking status with a rise from 4.569 to 4.621.
Read more >
The Scientist assumes a technical expert role within the World Health Organization and among United Nations agencies, partners and Member States in the area of research on fertility, subfertility and infertility. The Scientist will conceptualize and implement research in this field, ensure its compliance with the highest scientific and ethical standards, and promote the implementation of the results of this global work.
Qualifications: Master's degree in medicine, reproductive medicine, public health, epidemiology or related field. At least 7 years of experience in infertility, with at least 3 years of experience relating to low or middle income countries. Direct experience working in infertility research.
Read more >
Which techniques used in the study of single cell analysis are most effective?
This Special Series assesses current state-of-the-art techniques used in the field, the information that can be obtained by this mode of study and the limitations that it presents.
The 32nd Annual Meeting of ESHRE has been held in Helsinki, Finland, from 3 to 6 July 2016.
Find out more on our website dedicated to ESHRE 2016.
You need to log in to access some pages of the ESHRE website. Some pages are further restricted to ESHRE members.
> Login / MyESHRE
> Manage account
> Create a new account
> Password forgotten?
Find more information about the history, bylaws, mission, governing bodies and affiliated societies of ESHRE.
ESHRE members can find more vacancies and/or submit a job request on ESHRE's Job board